文献速递颈动脉与弓上血管血液透析通路

经桡动脉入路无鞘8Fr Optimo球囊导引导管系统行颈动脉支架置入术

Carotid Artery Stenting Using Sheathless 8Fr Optimo Balloon Guide Catheter System via Transradial Access.
PubMed 文献 · Ann Vasc Surg · 2025-04-15

该回顾性研究分析了2023年4月至2024年11月共30例经桡动脉入路使用无鞘8Fr Optimo球囊导引导管行颈动脉支架置入术的病例,技术成功率为97%,1例因桡动脉痉挛转为肱动脉入路。作者认为该技术安全可行,可保留经桡动脉入路的微创性并提高器械稳定性,可能降低栓塞风险。

要点

  • 无鞘8Fr Optimo球囊导引导管经桡动脉入路行颈动脉支架置入术技术成功率为97%。
  • 30天主要安全终点包括入路相关重大并发症、卒中、心肌梗死和死亡,本组未见重大并发症或不良事件。
  • 作者认为该技术安全可行,并建议开发经桡动脉入路专用的低外径器械以改善操作结果。

核心结论

  • 作者经验提示,无鞘8Fr球囊导引导管经桡动脉入路行颈动脉支架置入术安全可行,保留了经桡动脉入路的微创性,提高了器械稳定性,并可能降低栓塞风险。

研究设计与样本

  • 回顾性分析2023年4月至2024年11月共30例经桡动脉入路使用无鞘8Fr Optimo球囊导引导管行颈动脉支架置入术的病例。

主要发现

  • 共纳入30例,中位年龄77岁,男性占90%,症状性病变占42%,中位狭窄率79%,右侧颈动脉占63%。
  • 无鞘球囊导引导管插入和导航成功29例(97%),1例(3%)因桡动脉痉挛转为肱动脉入路。
  • 球囊充盈用于血流控制和器械稳定在23例(77%)中实施,所有病例支架置入成功,无重大并发症或不良事件。

临床怎么用

  • 作者认为,无鞘8Fr球囊导引导管经桡动脉入路行颈动脉支架置入术安全可行,并建议进一步开发经桡动脉入路专用的低外径器械以改善操作结果和扩大在神经介入中的应用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The transradial approach (TRA) is a less invasive alternative for carotid artery stenting (CAS). However, limited device availability has restricted its application, and reports on balloon guide catheters (BGCs) in TRA are scarce. This study reports the initial experience with sheathless 8Fr BGC in CAS via TRA. METHODS: We retrospectively analyzed cases of CAS performed with a sheathless 8Fr Optimo BGC (Tokai Medical Products, Aichi, Japan) via TRA from April 2023 to November 2024. Patient demographics, procedural details, and outcomes were evaluated. The primary efficacy endpoint was the technical success rate, while the primary safety endpoint was a composite of major access-related complications, stroke, myocardial infarction, and death within 30 days. RESULTS: A total of 30 cases were included (median age 77 years; 90% male). Symptomatic lesions were present in 42%, with a median stenosis rate of 79%, and 63% involved the right carotid artery. Sheathless BGC insertion and navigation succeeded in 29 cases (97%), with 1 case (3%) requiring conversion to brachial access due to radial artery spasm. Balloon inflation for flow control and device stabilization was performed in 23 cases (77%). CAS was successful in all cases, with no major complications or adverse events. CONCLUSION: Our experience suggests that the sheathless 8Fr BGC is safe and feasible for CAS via TRA. This approach preserves the minimally invasive nature of TRA while improving device stability and potentially reducing embolic risk. Further development of TRA-specific low-profile devices may enhance procedural outcomes and broaden adoption in neurointervention.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Imahori T, Miyake S, Maeda I, et al. Carotid Artery Stenting Using Sheathless 8Fr Optimo Balloon Guide Catheter System via Transradial Access. Ann Vasc Surg. 2025. PMID: 40239765. doi:10.1016/j.avsg.2025.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。